Tresiba FlexTouch U200 (Insulin Degludec)

Additional information

Tresiba FlexTouch U200 (Insulin Degludec) is typically injected once daily anytime during the day. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Your required dose of insulin depends on how much natural insulin your pancreas is producing and how well your body is able to use the insulin. It is only injected subcutaneously (under the skin), not intravenously (into the vein) or intramuscularly (into the muscle). Inject into the thigh, upper arm, or abdomen. With each injection, change the injection site within the particular area of skin that you used. This may reduce the risk of developing lumps or skin pitting. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you forget a dose, contact your pharmacist.
 
WARNING: Hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar) may result from changes in meal pattern (e.g., type of foods eaten, timing of meals), changes in the level of physical activity, increased work or exercise without eating, or changes to coadministered medications. Any change of insulin regimen should be made cautiously and only under medical supervision. Use of long-acting insulin preparations such as Tresiba may delay recovery from hypoglycemia. Glucose monitoring is recommended for all patients with diabetes. Do not use Tresiba FlexTouch U200 (Insulin Degludec) if your notice anything unusual about its appearance, such as cloudiness, discoloration, or clumping.

In addition to its desired action, Tresiba FlexTouch U200 (Insulin Degludec) may cause some side effects, notably:
It may cause redness, itching, or swelling at the site of the injection.
It may cause signs of low blood sugar (hypoglycemia): headache, rapid heartbeat, temporary changes in vision, drowsiness, feeling confused and difficulty in concentrating.
It may cause fluid retention causing swollen joints. 
 
Contraindications: Hypersensitivity to insulin degludec or any component of the formulation. Do not use during episodes of hypoglycemia (low blood sugar). 
 
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. 
 
A treatment with Tresiba FlexTouch U200 (Insulin Degludec) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Tresiba FlexTouch U200 (Insulin Degludec)